SEARCH

SEARCH BY CITATION

References

  • 1
    Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998; 28: 86880.
  • 2
    Burroughs AK, Patch D. Primary prevention of bleeding from oesophageal varices. N Engl J Med 1999; 340: 10335.
  • 3
    Lebrec D. Primary prevention of variceal bleeding. What's new? Hepatology 2001; 33: 10034.
  • 4
    Garcia-Pagan JC, Bosch J. Pharmacological prevention of variceal bleeding. New developments. Baillieres Clin Gastroenterol 1997; 11: 27187.
  • 5
    Pagliaro L, D'Amico G, Sorensen TIA, et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 1992; 77: 5970.
  • 6
    Garcia-Tsao G, Grace ND, Groszmann RJ, et al. Short term effects of propranolol on portal venous pressure. Hepatology 1986; 6: 1016.
  • 7
    Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet 1995; 346: 10569.
  • 8
    Luca A, D'Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212: 41121.
  • 9
    Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol 1997; 26: 31224.
  • 10
    Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of variceal bleeding: a meta-analysis. Ann Intern Med 1995; 123: 2807.
  • 11
    Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of oesophageal variceal ligation. Hepatology 2001; 33: 8027.
  • 12
    Moher D, Cook DJ, Eastwood S, Olkin I, Rennei D, Stroup DF. Improving the quality of reports of meta-analysis of randomized controlled trials: the QUOROM statement. Lancet 1999; 354: 1896900.
  • 13
    Franchis RD. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology, and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 84652.
  • 14
    Petitti DB. Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis, 2nd edn. New York, USA: Oxford University Press, 2000.
  • 15
    Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control Clin Trials 1996; 17: 112.
  • 16
    Anonymous. Glossary. Terms used in therapeutics. Ann Intern Med 2003; 139: A19.
  • 17
    Khuroo MS, Khuroo MS, Farahat KLC. Molecular adsorbent recirculating system (MARS) for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transplant 2004; 10: 1099106.
  • 18
    Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow up data. Biometrics 1985; 41: 5568.
  • 19
    Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 17788.
  • 20
    Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 62934.
  • 21
    Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 86772.
  • 22
    Cucherat M, Biossel JP, Leizorovicz A. EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed 1997; 53: 18790.
  • 23
    Chen CY, Sheu MZ, Su SY. Prophylactic endoscopic variceal ligation (EVL) with multiple band ligator for oesophageal varices (Abstract). Gastroenterology 1998; 114: A1224.
  • 24
    Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propanolol for the primary prevention of variceal bleeding. N Engl J Med 1999; 340: 98893.
  • 25
    De BK, Ghoshal UC, Das T, Santra A, Biswas PK. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 1999; 14: 2204.
  • 26
    Jutbha R, Jensen DM, Martin P, et al. Initial report of a randomized, prospective study of prophylactic propranolol compared to rubber band ligation for prevention of first variceal hemorrhage in cirrhotics with large oesophageal varices (Abstract). Gastroenterology 2000; 118: A212.
  • 27
    de la Mora JG, Farca-Belsaguy AA, Uribe M, de Hoyos-Garza A. Ligation vs propranolol for primary prophylaxis of variceal bleeding using multiple band ligator and objective measurements of treatment adequacy: preliminary results (Abstract). Gastroenterology 2000; 118: A6511.
  • 28
    Lui HF, Stanley AJ, Forrest EH, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol and isosorbide mononitrate. Gastroenterology 2002; 123: 73544.
  • 29
    Lo G-H, Chen W-C, Chen M-H, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc 2004; 59: 3338.
  • 30
    Schepke M, Kleber G, Nurnberg D, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2004; 40: 6572.
  • 31
    Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282: 105460.
  • 32
    Balk EM, Bonis PAL, Moskowitz H, et al. Correlation of quality measures with estimates of treatment effect in meta-analysis of randomized controlled trials. JAMA 2002; 287: 297382.